Trial Profile
A Randomized Study to Evaluate the Efficacy of Ingenol Mebutate on Actinic Keratoses and Field Cancerization Compared to Cryotherapy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Aug 2021
Price :
$35
*
At a glance
- Drugs Ingenol mebutate (Primary)
- Indications Actinic keratosis
- Focus Therapeutic Use
- 23 Sep 2019 Status changed from active, no longer recruiting to completed.
- 04 Jan 2018 Status changed from recruiting to active, no longer recruiting.
- 07 Aug 2017 Status changed from not yet recruiting to recruiting.